HomeServicesFormulation Development

Generic Formulation Development Services

Design, optimize, and scale robust pharmaceutical formulations that meet complex regulatory requirements and match reference product performance.

Request Formula Feasibility Assessment

What is generic formulation development?

Generic formulation development is the process of designing a drug product that matches the reference product in quality, performance, stability, manufacturability, and regulatory expectations. It includes excipient selection, process design, prototype trials, dissolution optimization, stability evaluation, and scale-up readiness.

Formulation Workflow

From lab-scale development to production readiness — with Engineering Batch as the critical bridge.

Steps 1 – 4

Lab-Scale Development

STEP 01

API & Product Understanding

STEP 02

Prototype Formula Development

STEP 03

Lab-Scale Optimization

STEP 04

Stability & Packaging Check

Scale
Up
Critical Scale-Up Gate

05

Engineering
Batch

Bridging lab success with real production behavior.

Go
Live

Steps 6 – 9

Production Readiness

STEP 06

Production Scale-Up

STEP 07

Tech Transfer & Validation Support

STEP 08

Commercial Manufacturing Readiness

STEP 09

Manufacturing Troubleshooting

Many formulation projects fail during scale-up — not during lab trials. KH Scientific Solutions helps bridge this critical gap with real industrial experience.

Technical Problems We Solve

From lab-scale trials to commercial manufacturing, we help pharmaceutical teams diagnose formulation and process challenges before they become costly delays.

Dissolution Failure

Inability to match the f2 profile of the reference product across required dissolution media.

Poor Stability

Unexpected degradation or physical changes during accelerated and long-term stability studies.

Assay Variation

Content uniformity or assay fluctuation issues, especially in low-dose solid oral formulations.

Process Failure

Sticking, capping, lamination, or poor powder flow during manufacturing and compression operations.

Scale-Up Risk

Formulas that perform well at lab scale but fail during pilot or commercial batch manufacturing.

Unoptimized Process

We apply QbD and PAT principles to identify critical variables, eliminate unnecessary steps, and build a robust, streamlined manufacturing process.

Key Development & Manufacturing Deliverables

  • Active & Inactive Raw Material Specifications
  • Manufacturing Formula / Master Formula
  • Detailed Processing Instructions with Critical Process Parameters (CPPs)
  • Comparative Dissolution & Process Optimization Strategy
  • Pilot / Engineering / Commercial BMR Review & Participation
  • Scale-Up & Technology Transfer Support
  • Process Validation Protocol
  • Manufacturing Troubleshooting & Process Improvement
  • Finished Product Specifications

Leadership

Technical Leadership Team

Supported by a multidisciplinary pharmaceutical technical team with expertise in formulation development, analytical support, GMP documentation, process scale-up, manufacturing troubleshooting, and commercial technology transfer.

Ahmed Nabil — Founder & Technical Lead

Ahmed Nabil

Founder & Technical Lead

20+ years of hands-on experience in generic pharmaceutical formulation development, scale-up, troubleshooting, and commercial technology transfer across MENA pharmaceutical markets.

LinkedIn Profile

Capabilities

Dosage Form Expertise

Tablets

Compressed solid dosage forms

Capsules

Hard gelatin / filled units

Suspensions

Dispersed liquid systems

Semi-solids

Creams / gels / ointments

Liquids

Syrups / oral solutions

Sachets

Powder / granules

Injections

Vials / ampoules

Who This Service Is For

Our formulation development support is designed for specific challenges at different stages of the generic drug development lifecycle.

R&D Scientists

Formulation scientists who need expert guidance on complex dissolution, stability, or scale-up problems affecting development timelines.

R&D Managers

Managers overseeing multiple development projects who need additional technical bandwidth to meet regulatory submission deadlines.

Generic Drug Companies

Companies entering the MENA/GCC generic market needing end-to-end formulation development support for their product portfolio.

Technology Transfer Teams

Manufacturing teams transferring established formulations to new sites who need technical documentation and validation support.

Case Study

BCS Class II Tablet

Dissolution Failure Resolution: From 42% to 85% f2 Match in 8 Weeks

A generic manufacturer in Egypt had a BCS Class II tablet that consistently failed to match the reference product's dissolution profile across pH 4.5, 6.8, and water media. After 18 months of internal development, they engaged KH Scientific Solutions to resolve the issue.

Our team identified the root cause as particle size specification drift in the API coupled with a suboptimal wetting agent concentration. Through a structured DoE approach, we redesigned the granulation process and optimized surfactant concentration. The client achieved f2 > 50 in all required media and successfully submitted to EDA within the same development cycle.

8 weeks to resolution f2 >50 across all media Successful EDA submission

Submit Your Formulation Challenge

Describe your current R&D roadblock below. Our team will review it and respond with a technical roadmap within 48 hours — no obligation.

Your information is kept confidential and never shared.